Characterization of a Novel Oral Small Molecule PTH1R Agonist: Sustained Control of Serum Calcium and Modulation of Bone Biomarkers in TPTx Rats by Septerna | Sep 30, 2024 | Uncategorized
Characterization of a Novel Oral Small Molecule PTH1R Agonist: Proof of Concept for an Alternative to Injectable Peptide-based Therapy for Hypoparathyroidism by Septerna | Jun 3, 2024 | Uncategorized
A Novel Oral Small Molecule Antagonist Targeting TSHR Improves Hyperthyroidism in an in vivo Model of Graves’ Disease by Septerna | Jun 3, 2024 | Uncategorized
Recent Comments